Details of the Drug

General Information of Drug (ID: DM957CK)

• Drug Name: Nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime
• Synonyms: CHEMBL598343; nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 285.3
  Logarithm of the Partition Coefficient (xlogp); 2.4
  Rotatable Bond Count (rotbonds); 6
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: C15H15N3O3
  IUPAC Name: [(E)-pyridin-3-ylmethylideneamino] N-(4-ethoxyphenyl)carbamate
  Canonical SMILES: CCOC1=CC=C(C=C1)NC(=O)O/N=C/C2=CN=CC=C2
  InChI: InChI=1S/C15H15N3O3/c1-2-20-14-7-5-13(6-8-14)18-15(19)21-17-11-12-4-3-9-16-10-12/h3-11H,2H2,1H3,(H,18,19)/b17-11+
  InChIKey: LKOKEOYUZBYMCC-GZTJUZNOSA-N
• Cross-matching ID:
  PubChem CID: 20872722
  TTD ID: D0B0IO

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.